In Silico Analysis of Conformational Changes Induced by Normal and Mutation of Macrophage Infectivity Potentiator Catalytic Residues and its Interactions with Rapamycin
Tóm tắt
The Legionella pneumophila (Lp), human pathogen, causes severe and often fatal Legionnaires’ disease, produces a major virulence factor, termed ‘macrophage infectivity potentiator protein’ (Mip), that is necessary for optimal multiplication of the bacteria within human alveolar macrophages. Mip exhibits peptidyl prolyl cis–trans isomerase (PPIase) activity, which can be inhibited by rapamycin and FK506. It was previously shown that substitutions at the catalytic residues, aspartate-142 position replaced to leucine-142 and tyrosine-185 position replaced to alanine-185 strongly reduces the PPIase activity of Mip proteins. Therefore, we aim to develop an in silico mutagenesis model for both important catalytic residues, validated the stability of the mutated model. Further, we have docked the known inhibitor rapamycin with Lp Mip (native) and mutants (D142L and Y185A) to analyze the conformational and binding mode. Electrostatic contributions and van der Waals interactions are the major driving forces for rapamycin binding and largely responsible for the binding differences between the Lp Mip (native and mutated) proteins.
Tài liệu tham khảo
McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR (1997) Legionnaires’ disease. Isolation of the bacterium and demonstration of its role in other respiratory disease. N Engl J Med 297:1197–1203
Winn WC (1988) Legionnaires’ disease: historical perspective. Clin Microbiol Rev 1:60–81
Rowbotham TJ (1980) Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. J Clin Pathol 33:1179–1183
Rowbotham TJ (1986) Current views on the relationship between amoebae, Legionellae and man. Isr J Med Sci 22:678–689
Steinert M, Ott M, Luök PC, Hacker J (1994) Studies on the uptake and intracellular replication of Legionella pneumophila in protozoa and in macrophage-like cells. FEMS Microbiol Ecol 15:299–308
Cianciotto NP, Stamos JV, Kamp DW (1995) Infectivity of Legionella pneumophila MIP mutant for alveolar epithelial cells. Curr Microbiol 30:247–250
Wintermeyer E, Ludwig B, Steinert M, Schmidt B, Fischer G, Hacker J (1995) Influence of site specifically altered MIP proteins on intracellular survival of Legionella pneumophila in eucaryotic cells. Infect Immun 63:4576–4583
Juli C, Sippel M, Jager J, Thiele A, Weiwad M, Schweimer K, Rosch P, Steinert M, Sotriffer CA, Holzgrabe U (2011) Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. J Med Chem 54:277–283
Riboldi-Tunnicliffe A, Konig B, Jessen S, Weiss MS, Rahfeld J, Hacker J, Fischer G, Hilgenfeld R (2001) Crystal structure of MIP, a prolylisomerase from Legionella pneumophila. Nat Struct Biol 8:779–783
Fischer G, Bang H, Ludwig B, Mann K, Hacker J (1992) Mip protein of Legionella pneumophila exhibits peptidyl-prolyl cis/trans isomerase (PPIase) activity. Mol Microbiol 6:1375–1383
Guba M, Breitenbuch VP, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128–135
Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, Ke H (2002) Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes. Proc Natl Acad Sci USA 99:12037–12042
Ke H, Huai Q (2003) Structures of calcineurin and its complexes with immunophilins–immunosuppressants. Biochem Biophys Res Commun 311:1095–1102
Sharma VK, Li B, Khanna A, Sehajpal PK, Suthanthiran M (1994) Which way for drug-mediated immunosuppression. Curr Opin Immunol 6:784–790
Vijayan R, Subbarao N, Mallick BN (2007) In silico modeling of \(\alpha\)-1A adrenoceptor: interactions of its normal and mutated active sites with noradrenaline as well as its agonist and antagonist. Am J Biochem Biotechnol 3:216–224
Shanmugam A, Natarajan J (2014) Combination of site directed mutagenesis and secondary structure analysis predicts the amino acids essential for stability of M. leprae MurE. Interdiscip Sci Comput Life Sci 6:40–47
Ludwig B, Rahfeld J, Schmidt B, Mann K, Wintermeyer E, Fischer G, Hacker J (1994) Characterization of Mip proteins of Legionella pneumophila. FEMS Microbiol Lett 118:23–30
Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, Sali A (2009) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291–325
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 7:7–20
Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucl Acids Res 33:W306–W310
Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. Proteins Struct Funct Bioinform 62:1125–1132
The PyMOL molecular graphics system, version 1.5.0.4 Schrödinger, LLC
Huang B, Schroeder M (2006) LIGSITE csc: predicting ligand binding sites using the Connolly surface and degree of conservation. BMC Struct Biol 6:19
Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J (2006) CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34:116–118
Boyle NMO, James BM, Morley CA, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Accelrys Software Inc. (2013) Discovery studio modeling environment, release 4.0. Accelrys Software Inc., San Diego